Income Statement
JAGUAR HEALTH, INC.
JAGX
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY |
|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
11.69 | 9.76 | 11.96 | 4.34 | 9.39 | 5.78 | 4.42 | 4.36 | - | - |
|
Cost of Revenue
|
1.96 | 2.04 | 2.02 | 2.33 | 3.28 | 3.82 | 2.77 | 0.88 | 0.05 | 0.12 |
|
Gross Profit
|
9.73 | 7.72 | 9.94 | 2.00 | 6.11 | 1.96 | 1.65 | 3.48 | -0.05 | -0.12 |
|
Operating Expenses
|
34.80 | 35.18 | 35.52 | 32.18 | 20.80 | 19.32 | 35.24 | 38.61 | 13.73 | 12.70 |
|
Research & Development
|
16.54 | 18.60 | 17.65 | 15.08 | 6.41 | 5.82 | 5.15 | 4.27 | 7.21 | 6.48 |
|
Selling, General & Administrative
|
18.26 | 16.59 | 17.87 | 17.10 | 14.39 | 13.50 | 12.28 | 11.25 | 5.98 | 5.34 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-25.06 | -27.46 | -25.58 | -30.18 | -14.70 | -17.36 | -33.59 | -35.13 | -13.78 | -12.83 |
|
Non-Operating Income
|
14.19 | 14.44 | 22.82 | 22.42 | 19.11 | 21.17 | -1.44 | 0.02 | - | - |
|
Interest Income
|
- | - | - | - | - | - | - | - | - | - |
|
Interest Expense
|
0.42 | 6.38 | 12.72 | 8.42 | 2.79 | 5.73 | 2.63 | 1.21 | 0.99 | 3.32 |
|
Other Non-Op Income / Expense
|
0.05 | 0.20 | 0.95 | -0.77 | 0.19 | 0.08 | 0.32 | 0.09 | -0.01 | -0.03 |
|
Income Before Tax
|
-0.34 | -0.13 | -42.10 | -48.00 | -33.80 | -38.53 | -32.15 | -35.15 | - | - |
|
Income Tax Expense
|
-0.76 | -0.60 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | -13.18 | - | - |
|
Non-Controlling Interest
|
-0.76 | -0.60 | -0.94 | -0.01 | - | - | - | - | - | - |
|
Net Income
|
-38.49 | -41.30 | -0.94 | -0.01 | -33.81 | -38.54 | -32.15 | -21.97 | -14.73 | -16.29 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY |
|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-23.16 | -25.45 | -23.60 | -28.46 | -12.97 | -15.63 | -32.27 | -34.54 | -13.73 | -12.82 |
|
Earnings Per Share (Basic)
|
-130.69 | -1.79 | -36.18 | -1.18 | - | - | - | - | - | - |
|
Diluted EPS
|
-130.69 | -1.79 | -36.18 | -1.18 | - | - | - | - | - | - |
|
Weighted Average Shares
|
0.29 | 23.07 | 1.31 | 44.71 | - | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
0.29 | 23.07 | 1.31 | 44.71 | - | - | - | - | - | - |
|
Comprehensive Income
|
-38.31 | -41.27 | - | - | - | - | - | - | - | - |